NO20030156D0 - Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav - Google Patents

Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav

Info

Publication number
NO20030156D0
NO20030156D0 NO20030156A NO20030156A NO20030156D0 NO 20030156 D0 NO20030156 D0 NO 20030156D0 NO 20030156 A NO20030156 A NO 20030156A NO 20030156 A NO20030156 A NO 20030156A NO 20030156 D0 NO20030156 D0 NO 20030156D0
Authority
NO
Norway
Prior art keywords
methods
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
NO20030156A
Other languages
English (en)
Other versions
NO20030156L (no
Inventor
Gary Maurice Dull
Original Assignee
Targacept Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Targacept Inc filed Critical Targacept Inc
Publication of NO20030156D0 publication Critical patent/NO20030156D0/no
Publication of NO20030156L publication Critical patent/NO20030156L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NO20030156A 2000-07-14 2003-01-13 Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav NO20030156L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/616,187 US6743812B1 (en) 2000-07-14 2000-07-14 Pharmaceutical compositions and methods for use
PCT/US2001/040689 WO2002005801A2 (en) 2000-07-14 2001-05-04 Compositions containing diacyltartaric salts of (e)-metanicotine

Publications (2)

Publication Number Publication Date
NO20030156D0 true NO20030156D0 (no) 2003-01-13
NO20030156L NO20030156L (no) 2003-03-13

Family

ID=24468381

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030156A NO20030156L (no) 2000-07-14 2003-01-13 Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav

Country Status (13)

Country Link
US (1) US6743812B1 (no)
EP (1) EP1317267A2 (no)
JP (1) JP2004503589A (no)
CN (1) CN1452486A (no)
AU (1) AU2001261828A1 (no)
BR (1) BR0112131A (no)
CA (1) CA2415906A1 (no)
HU (1) HUP0301594A2 (no)
IL (1) IL153487A0 (no)
NO (1) NO20030156L (no)
PL (1) PL365602A1 (no)
WO (1) WO2002005801A2 (no)
ZA (1) ZA200300132B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6979695B2 (en) * 1996-04-23 2005-12-27 Targacept, Inc. Compounds capable of activating cholinergic receptors
US6708064B2 (en) * 2000-02-24 2004-03-16 Ali R. Rezai Modulation of the brain to affect psychiatric disorders
US6432954B1 (en) * 2000-07-14 2002-08-13 Targacept, Inc. Pharmaceutical compositions and methods for use
UA88792C2 (ru) * 2004-11-10 2009-11-25 Таргасепт, Інк. Гидроксибензоатные соли метаникотиновых соединений
US7459469B2 (en) 2004-11-10 2008-12-02 Targacept, Inc. Hydroxybenzoate salts of metanicotine compounds
EP2021325A2 (en) * 2006-05-09 2009-02-11 AstraZeneca AB Salt forms of (2s)-(4e)-n-methyl-5-[3-(5-isopropoxypyridin)yl]-4-penten-2-amine
TWI389889B (zh) * 2006-05-09 2013-03-21 Targacept Inc （２ｓ）-（４ｅ）-ｎ-甲基-５-〔３-（５-異丙氧基吡啶）基〕-４-戊烯-２-胺之新穎多晶型
WO2008034041A2 (en) * 2006-09-15 2008-03-20 Astrazeneca Ab Therapeutic combinations
WO2008091588A1 (en) 2007-01-22 2008-07-31 Targacept, Inc. Intranasal, buccal, and sublingual administration of metanicotine analogs
CN101772343A (zh) * 2007-07-31 2010-07-07 塔格赛普有限公司 (2s)-(4e)-n-甲基-5-(3-(5-异丙氧基吡啶)基)-4-戊烯-2-胺的经皮给药
EP2574188A4 (en) * 2010-05-20 2015-09-02 Targacept Inc NOVEL PROCESS FOR THE PREPARATION OF ARYL SUBSTITUTED OLEFIN AMINES

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1409551A (en) 1972-04-14 1975-10-08 Allen & Hanburys Ltd Cyclopent a indene derivatives
US4528290A (en) 1984-01-30 1985-07-09 Eli Lilly And Company Stimulating dopamine D-1 receptors
GB8606254D0 (en) 1986-03-13 1986-04-16 Wyeth John & Brother Ltd Substituted pyrimidoindoles
FR2664600B1 (fr) 1990-07-16 1994-09-02 Rhone Poulenc Sante Nouveau sel derive de la dialcoylaminoalcoyl-sulfonyl-26 pristinamycine iib.
US5723477A (en) 1994-11-10 1998-03-03 Sibia Neurosciences, Inc. Modulators of acetylcholine receptors
CA2206119C (en) * 1994-12-12 2008-05-13 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain, inflammation and spasm
ATE334120T1 (de) 1995-01-06 2006-08-15 Targacept Inc Pharmazeutische zusammensetzungen zur vorbeugung und behandlung von störungen des zentralnervensystems
CA2197838C (en) * 1996-03-01 2004-09-28 Mark S. Miller Mouthfeel and lubricity enhancing composition
US5663356A (en) 1996-04-23 1997-09-02 Ruecroft; Graham Method for preparation of aryl substituted alefinic secondary amino compounds

Also Published As

Publication number Publication date
AU2001261828A1 (en) 2002-01-30
EP1317267A2 (en) 2003-06-11
HUP0301594A2 (hu) 2003-08-28
JP2004503589A (ja) 2004-02-05
BR0112131A (pt) 2003-09-02
CA2415906A1 (en) 2002-01-24
NO20030156L (no) 2003-03-13
ZA200300132B (en) 2004-04-06
PL365602A1 (en) 2005-01-10
US6743812B1 (en) 2004-06-01
IL153487A0 (en) 2003-07-06
WO2002005801A3 (en) 2002-08-08
WO2002005801A2 (en) 2002-01-24
CN1452486A (zh) 2003-10-29

Similar Documents

Publication Publication Date Title
DK1202941T3 (da) Gipssammensætninger og beslægtede fremgangsmåder
DK1242095T3 (da) Antimikrobielle sammensætninger og fremgangsmåder til anvendelse deraf
DK1329456T3 (da) Glucopyranosyloxybenzylbenzenderivater og medicinske sammensætninger indeholdende samme
DK1524266T3 (da) Farmaceutisk sammensætning
DK1353919T3 (da) Hidtil ukendte quinuclidinderivater og medicinale sammensætninger indeholdende samme
FI20105657A (fi) Farmaseuttisia koostumuksia
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
IS6934A (is) Nýjar spírótrísýklískar afleiður og notkun þeirrasem fosfódíesterasa-7-hindrar
ITTO20010008A0 (it) Formulazione farmaceutica
ITMI20010748A0 (it) Composizioni farmaceutiche
NO20025450L (no) Ny farmasöytisk sammensetning
NO20044192L (no) 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
DK1354888T3 (da) Glukopyranosyloxypyrazolderivater og anvendelse deraf i medikamenter
DK1251848T3 (da) Gyraseinhibitorer og anvendelse deraf
DK1339292T3 (da) Sammensætning og fremgangsmåde
DK1429769T3 (da) Nye formuleringer og anvendelse deraf
IS2841B (is) Samstæða hluta og lyfjasamsetningar
NO20025158L (no) Lipidpreparat og anvendelse derav
NO20026123L (no) Farmasöytiske sammensetninger
NO20034778L (no) Farmasöytiske sammensetninger for oral og topisk anvendelse
NO20043333L (no) Farmasoytiske parvastatinformuleringer og fremgangsmater for anvendelse av dem
NO20030156D0 (no) Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
NO20031095D0 (no) Farmasöytiske sammensetninger
NO20022022L (no) N-guanidinoalkylamider, deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application